| |
|
       |
|
|
- Mark H. Einstein, MD, MSc: Assistant Professor, Director of Clinical Research, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women’s Health, Albert Einstein College of Medicine and Montefiore Medical Center, New York. Dr. Einstein’s clinical focus is in the development of immunotherapeutics, primarily in the area of women’s health with a focus on HPV-related lesions.
- Ian Hector Frazer, PhD: Director, Centre for Immunology and Cancer Research, University of Queensland, Australia. Dr. Frazer’s research into HPV pathogenesis and prevention resulted in discovery and development of the virus like particle technology enabling the two vaccines recently licensed to help prevent cervical cancer.
- Warner K. Huh, MD: Assistant Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama, Birmingham (UAB) and Associate Scientist, UAB Comprehensive Cancer Center. Dr. Huh’s expertise is in the development of clinical approaches for the treatment of cervical lesions resulting from HPV infection.
- W. Martin Kast, PhD: Walter A. Richter Cancer Research Chair; Professor of Molecular Microbiology & Immunology and Obstetrics & Gynecology; Norris Comprehensive Cancer Center, University of Southern California. Dr. Kast’s research is focused in the areas of therapeutic vaccine development for the treatment of prostate cancer and HPV-linked cancers such as cervical cancer.
- Myron J. Levin, MD: Professor of Pediatrics and Medicine, University of Colorado Health Sciences Center. Dr. Levin’s primary research focus is in pediatric infectious diseases and the design of both prophylactic and therapeutic vaccines.
- Richard Ulevitch, PhD: Chairman, Department of Immunology, The Scripps Research Institute, San Diego, California. Dr. Ulevitch’s research is centered on understanding the innate immune system and the factors that contribute to the body’s identification of pathogens and the resulting immune responses.
- Jeffrey Weber, MD, PhD: Professor, Department of Interdisciplinary Oncology and Head, Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center in Florida. Dr. Weber’s research and clinical focus is on understanding how to stimulate the body’s immune system to eliminate various cancers, including melanoma and HPV-induced cervical lesions.
- T.-C. Wu, MD, PhD: Professor of Pathology, Oncology, Obstetrics and Gynecology, The Johns Hopkins University School of Medicine; Professor of Molecular Microbiology and Immunology, The Johns Hopkins University, Bloomberg School of Public Health; Research Director of Gynecologic Pathology; Pathologist, The Johns Hopkins Hospital. Dr. Wu’s research has been in the area of vaccine development for the treatment of cervical lesions caused by HPV.
|
|
